Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Gilead, Baxter Ramp Up Lobbying on Trump’s HIV, Kidney Plans

May 23, 2019, 11:01 AM

The Department of Health and Human Services beat all other federal agencies as the most popular stop for lobbyists during the first quarter. That continues its track record of topping the lobbying list since 2015.

HIV Hot Topic: President Donald Trump’s vow to curtail HIV infections in the next decade may have sparked some interest in lobbying the HHS. Gilead Sciences, which holds the patent on the HIV prevention drug Truvada, sent lobbyists to discuss policy related to the virus.

PhRMA Top Talker: The Pharmaceutical Research and Manufacturers of America is on track to remain the top lobbyer of the ...